Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D2022
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 402 $627,570 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $627,570 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling <1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp as the prime contractor. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion across multiple regional awards. The IDC serves as a primary vehicle for DLA to efficiently procure essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. In addition, Amerisourcebergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The original solicitation, issued by DLA Troop Support Medical Supply Chain, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The solicitation is expected to be released in March 2024 and remain open for 45 days, with a vendor conference scheduled prior to the closing date. The procurement is fully competitive, with the intention to make multiple awards for separate regions to ensure resilience and access to vital pharmaceuticals during contingencies or natural disasters. Award will be made to responsive and responsible offerors whose proposals are technically acceptable and offer the lowest overall price based on distribution fees.
Task orders
Show 40 more
Latest 50 of 402 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D2022?
SPE2DR25D2022 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D2022 worth?
Orders under SPE2DR25D2022 have obligated $627,570. SPE2DR25D2022's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D2022?
402 orders have been placed under SPE2DR25D2022, the latest on July 28, 2026.
Who can order from contract SPE2DR25D2022?
SPE2DR25D2022 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D2022 competed?
The extent of competition for SPE2DR25D2022 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV